Bioactive Peptides Against Fungal Biofilms

Infections caused by invasive fungal biofilms have been widely associated with high morbidity and mortality rates, mainly due to the advent of antibiotic resistance. Moreover, fungal biofilms impose an additional challenge, leading to multidrug resistance. This fact, along with the contamination of...

Full description

Bibliographic Details
Main Authors: Karen G. N. Oshiro, Gisele Rodrigues, Bruna Estéfani D. Monges, Marlon Henrique Cardoso, Octávio Luiz Franco
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.02169/full
id doaj-d9a606cf0e7849c58b156ebefc7dd92b
record_format Article
spelling doaj-d9a606cf0e7849c58b156ebefc7dd92b2020-11-24T20:42:49ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-10-011010.3389/fmicb.2019.02169462276Bioactive Peptides Against Fungal BiofilmsKaren G. N. Oshiro0Karen G. N. Oshiro1Gisele Rodrigues2Bruna Estéfani D. Monges3Marlon Henrique Cardoso4Marlon Henrique Cardoso5Octávio Luiz Franco6Octávio Luiz Franco7Octávio Luiz Franco8Programa de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, Universidade de Brasília, Brasília, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilCentro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilCentro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, BrazilPrograma de Pós-Graduação em Patologia Molecular, Faculdade de Medicina, Universidade de Brasília, Brasília, BrazilS-Inova Biotech, Programa de Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, BrazilCentro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, BrazilInfections caused by invasive fungal biofilms have been widely associated with high morbidity and mortality rates, mainly due to the advent of antibiotic resistance. Moreover, fungal biofilms impose an additional challenge, leading to multidrug resistance. This fact, along with the contamination of medical devices and the limited number of effective antifungal agents available on the market, demonstrates the importance of finding novel drug candidates targeting pathogenic fungal cells and biofilms. In this context, an alternative strategy is the use of antifungal peptides (AFPs) against fungal biofilms. AFPs are considered a group of bioactive molecules with broad-spectrum activities and multiple mechanisms of action that have been widely used as template molecules for drug design strategies aiming at greater specificity and biological efficacy. Among the AFP classes most studied in the context of fungal biofilms, defensins, cathelicidins and histatins have been described. AFPs can also act by preventing the formation of fungal biofilms and eradicating preformed biofilms through mechanisms associated with cell wall perturbation, inhibition of planktonic fungal cells’ adhesion onto surfaces, gene regulation and generation of reactive oxygen species (ROS). Thus, considering the critical scenario imposed by fungal biofilms and associated infections and the application of AFPs as a possible treatment, this review will focus on the most effective AFPs described to date, with a core focus on antibiofilm peptides, as well as their efficacy in vivo, application on surfaces and proposed mechanisms of action.https://www.frontiersin.org/article/10.3389/fmicb.2019.02169/fullantifungal peptidesfungal infectionsfungal biofilmsantimicrobial peptidesmechanisms of action
collection DOAJ
language English
format Article
sources DOAJ
author Karen G. N. Oshiro
Karen G. N. Oshiro
Gisele Rodrigues
Bruna Estéfani D. Monges
Marlon Henrique Cardoso
Marlon Henrique Cardoso
Octávio Luiz Franco
Octávio Luiz Franco
Octávio Luiz Franco
spellingShingle Karen G. N. Oshiro
Karen G. N. Oshiro
Gisele Rodrigues
Bruna Estéfani D. Monges
Marlon Henrique Cardoso
Marlon Henrique Cardoso
Octávio Luiz Franco
Octávio Luiz Franco
Octávio Luiz Franco
Bioactive Peptides Against Fungal Biofilms
Frontiers in Microbiology
antifungal peptides
fungal infections
fungal biofilms
antimicrobial peptides
mechanisms of action
author_facet Karen G. N. Oshiro
Karen G. N. Oshiro
Gisele Rodrigues
Bruna Estéfani D. Monges
Marlon Henrique Cardoso
Marlon Henrique Cardoso
Octávio Luiz Franco
Octávio Luiz Franco
Octávio Luiz Franco
author_sort Karen G. N. Oshiro
title Bioactive Peptides Against Fungal Biofilms
title_short Bioactive Peptides Against Fungal Biofilms
title_full Bioactive Peptides Against Fungal Biofilms
title_fullStr Bioactive Peptides Against Fungal Biofilms
title_full_unstemmed Bioactive Peptides Against Fungal Biofilms
title_sort bioactive peptides against fungal biofilms
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2019-10-01
description Infections caused by invasive fungal biofilms have been widely associated with high morbidity and mortality rates, mainly due to the advent of antibiotic resistance. Moreover, fungal biofilms impose an additional challenge, leading to multidrug resistance. This fact, along with the contamination of medical devices and the limited number of effective antifungal agents available on the market, demonstrates the importance of finding novel drug candidates targeting pathogenic fungal cells and biofilms. In this context, an alternative strategy is the use of antifungal peptides (AFPs) against fungal biofilms. AFPs are considered a group of bioactive molecules with broad-spectrum activities and multiple mechanisms of action that have been widely used as template molecules for drug design strategies aiming at greater specificity and biological efficacy. Among the AFP classes most studied in the context of fungal biofilms, defensins, cathelicidins and histatins have been described. AFPs can also act by preventing the formation of fungal biofilms and eradicating preformed biofilms through mechanisms associated with cell wall perturbation, inhibition of planktonic fungal cells’ adhesion onto surfaces, gene regulation and generation of reactive oxygen species (ROS). Thus, considering the critical scenario imposed by fungal biofilms and associated infections and the application of AFPs as a possible treatment, this review will focus on the most effective AFPs described to date, with a core focus on antibiofilm peptides, as well as their efficacy in vivo, application on surfaces and proposed mechanisms of action.
topic antifungal peptides
fungal infections
fungal biofilms
antimicrobial peptides
mechanisms of action
url https://www.frontiersin.org/article/10.3389/fmicb.2019.02169/full
work_keys_str_mv AT karengnoshiro bioactivepeptidesagainstfungalbiofilms
AT karengnoshiro bioactivepeptidesagainstfungalbiofilms
AT giselerodrigues bioactivepeptidesagainstfungalbiofilms
AT brunaestefanidmonges bioactivepeptidesagainstfungalbiofilms
AT marlonhenriquecardoso bioactivepeptidesagainstfungalbiofilms
AT marlonhenriquecardoso bioactivepeptidesagainstfungalbiofilms
AT octavioluizfranco bioactivepeptidesagainstfungalbiofilms
AT octavioluizfranco bioactivepeptidesagainstfungalbiofilms
AT octavioluizfranco bioactivepeptidesagainstfungalbiofilms
_version_ 1716821681744379904